Abstract
Recent studies indicate the existence of a maternal-autoantibody-related subtype of autism spectrum disorder (ASD). To date, a large number of studies have focused on describing patterns of brain-reactive serum antibodies in maternal-autoantibody-related (MAR) autism and some have described attempts to define the antigenic targets. This article describes evidence on MAR autism and the various autoantibodies that have been implicated. Among other possibilities, antibodies to neuronal surface protein Contactin Associated Protein 2 (CASPR2) have been found more frequently in mothers of children with neurodevelopmental disorders or autism, and two independent experimental studies have shown pathogenicity in mice. The N-methyl-D-aspartate receptor (NMDAR) is another possible target for maternal antibodies as demonstrated in mice. Here, we discuss the growing evidence, discuss issues regarding biomarker definition, and summarise the therapeutic approaches that might be used to reduce or prevent the transfer of pathogenic maternal antibodies.
Reference104 articles.
1. Autism Spectrum Disordershttps://www.who.int/news-room/fact-sheets/detail/autism-spectrum-disorders
2. DSM-5 Guidebook: The Essential Companion to the Diagnostic and Statistical Manual of Mental Disorders;Black,2014
3. Advancing the understanding of autism disease mechanisms through genetics
4. Perinatal and Neonatal Risk Factors for Autism: A Comprehensive Meta-analysis
5. The Role of the Immune System in Autism Spectrum Disorder
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献